We are excited to be exhibiting at Advanced Therapies Week, taking place January 17-20, 2023 in Miami, Florida, USA.

Recipharm will be represented by our acquired partners Vibalogics and ArrantaBio. These companies expand Recipharm’s specialized CDMO capabilities from preclinical-to-clinical and commercial approval for new biological modalities encompassing technologies based on live viruses and viral vectors, live-microbial biopharmaceutical products, nucleic acid-based mRNA and plasmid DNA production. If you would like to learn more, visit us on booth #211 or arrange a meeting with us.

For meeting requests during: submit through the contact us form on our website, or email below:

Maggie Angelova,